ALERUS director granted 1,772 ALRS shares
Zimmer Mary reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Zimmer Mary reported acquisition or exercise transactions in this Form 4 filing.
Alerus Financial Corp director Mary Zimmer received an annual equity award of 1,772 shares of common stock, issued at no cash cost to her under the Alerus Financial Corporation 2019 Equity Incentive Plan. Following this grant, she directly owns 12,374 shares, including 1,772 shares of restricted stock and 3,809 shares held jointly with her spouse.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,772 | $0.00 | $0.00 |
Footnotes (3)
- F1. All shares were acquired pursuant to an annual director award issued under the Alerus Financial Corporation 2019 Equity Incentive Plan.
- F2. Includes 1,772 shares of restricted stock.
- F3. Includes 3,809 shares held jointly with Ms. Zimmer's spouse.
Key Figures
Key Terms
2019 Equity Incentive Plan financial
restricted stock financial
annual director award financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ALRS director Mary Zimmer report on this Form 4?
What plan governed the ALRS equity award reported by Mary Zimmer?
AI-generated analysis. How Rhea-AI works. Not financial advice.